Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Securin MeSH Descriptor Data 2025


MeSH Heading
Securin
Tree Number(s)
D12.776.167.504
Unique ID
D064249
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D064249
Scope Note
Securin is involved in the control of the metaphase-anaphase transition during MITOSIS. It promotes the onset of anaphase by blocking SEPARASE function and preventing proteolysis of cohesin and separation of sister CHROMATIDS. Overexpression of securin is associated with NEOPLASTIC CELL TRANSFORMATION and tumor formation.
Entry Term(s)
PTTG Protein
Pituitary Tumor-Transforming Gene Protein
Pituitary Tumor-Transforming Proteins
Registry Numbers
0
Previous Indexing
Neoplasm Proteins (1997-2013)
Public MeSH Note
2014; was indexed under NEOPLASM PROTEINS 1997-2013
History Note
2014
Date Established
2014/01/01
Date of Entry
2013/07/08
Revision Date
2014/01/01
Securin Preferred
page delivered in 0.148s